Trial intelligence / Profile preview

Paliperidone ER in Schizophrenia

NCT02075528Phase 4Completed

Sponsor
Taipei City Hospital
Start
Jul 2009
Primary completion
May 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of paliperidone in schizophrenia, schizoaffective disorder, sponsored by Taipei City Hospital. Started Jul 2009; status: completed.

02

Drugs

paliperidone
03

Conditions

schizophreniaschizoaffective disorder

Beyond the preview

Go deeper on NCT02075528.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02075528.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call